I. Gil-Ibanez

Constitutive gp130 activation rapidly accelerates the transformation of human hepatocytes via an impaired oxidative stress response

D. Schmidt-Arras, S. Rose-John, A. Lohse, 2016, Oncotarget.

First- and Second-Line Targeted Systemic Therapy in Hepatocellular Carcinoma—An Update on Patient Selection and Response Evaluation

K. Schulze, H. Wege, J. von Felden, 2016, Diagnostics.

Sustained response after remdesivir and convalescent plasma therapy in a B-cell depleted patient with protracted COVID-19

M. Addo, U. Rosien, A. Stein, 2020, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Sequential Systemic Treatment in Advanced Hepatocellular Carcinoma Is Able to Prolong Median Survival to More than 3 Years in a Selected Real-World Cohort

A. Lohse, H. Ittrich, K. Schulze, 2020, Visceral Medicine.